Exchange: NASDAQ·Updated 07:30 PM EDT

ICUI News

News
all
press releases
ICU Medical CFO Sells 6,381 Shares for $1.1 Million
Key PointsThe sale involved shares equal to 10% of the CFO's direct equity stake held prior to the transaction...
Nasdaq News: Markets
ICU Medical CFO Sells 6,381 Shares for $1.1 Million
Key PointsThe sale involved shares equal to 10% of the CFO's direct equity stake held prior to the transaction...
Nasdaq News: Markets
More News
ICU Medical CFO Brian Bonnell Sells 9,307 Shares
Key PointsThe transaction involved shares equal to 13% of the stake held before the filing...
Nasdaq News: Markets
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure
Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.
Zacks
Ben Sousa Executes Sell Order: Offloads $401K In ICU Medical Stock
A substantial insider sell was reported on August 12, by Ben Sousa, Chief Information Officer at ICU Medical (NASDAQ:ICUI), based on the recent SEC filing. What Happened: After conducting a thorough analysis, Sousa soldread more...
Benzinga
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.read more...
Benzinga
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of +24.08% and +2.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of +11.97% and -0.97%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America
Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America PR Newswire AUSTIN, Texas, July 9, 2026 This expansion of IV solutions manufacturing will help...
PR Newswire
ICUI vs. SYK: Which Stock Should Value Investors Buy Now?
ICUI vs. SYK: Which Stock Is the Better Value Option?
Zacks

Advertisement|Remove ads.